Bicocca Open Archive

Logo unimib boa
CONTI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.039
AS - Asia 5.578
EU - Europa 5.076
SA - Sud America 826
Continente sconosciuto - Info sul continente non disponibili 744
AF - Africa 150
OC - Oceania 16
Totale 24.429
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.451
SG - Singapore 1.880
IT - Italia 1.381
CN - Cina 1.164
VN - Vietnam 897
DE - Germania 804
RU - Federazione Russa 637
HK - Hong Kong 629
BR - Brasile 591
CA - Canada 475
SE - Svezia 455
IE - Irlanda 364
GB - Regno Unito 348
UA - Ucraina 232
IN - India 223
FR - Francia 200
AT - Austria 150
FI - Finlandia 141
BD - Bangladesh 139
TR - Turchia 105
AR - Argentina 85
KR - Corea 82
ID - Indonesia 75
JP - Giappone 65
DK - Danimarca 64
IQ - Iraq 58
PK - Pakistan 52
PL - Polonia 52
ZA - Sudafrica 51
NL - Olanda 50
MX - Messico 46
ES - Italia 45
BE - Belgio 38
PH - Filippine 37
EC - Ecuador 35
CO - Colombia 33
SA - Arabia Saudita 29
VE - Venezuela 29
EG - Egitto 26
UZ - Uzbekistan 24
MA - Marocco 20
CZ - Repubblica Ceca 19
CL - Cile 18
CH - Svizzera 17
JM - Giamaica 16
CR - Costa Rica 15
MY - Malesia 14
AE - Emirati Arabi Uniti 13
EU - Europa 13
IR - Iran 13
LT - Lituania 13
AU - Australia 12
PE - Perù 11
DZ - Algeria 10
ET - Etiopia 9
HU - Ungheria 9
JO - Giordania 9
RO - Romania 9
TN - Tunisia 9
BO - Bolivia 8
KE - Kenya 8
PY - Paraguay 8
AL - Albania 7
NI - Nicaragua 7
PT - Portogallo 7
AZ - Azerbaigian 6
BH - Bahrain 6
PA - Panama 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
BG - Bulgaria 5
HN - Honduras 5
IL - Israele 5
KZ - Kazakistan 5
NP - Nepal 5
OM - Oman 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
GT - Guatemala 4
LV - Lettonia 4
MN - Mongolia 4
SI - Slovenia 4
SN - Senegal 4
BY - Bielorussia 3
KG - Kirghizistan 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
BB - Barbados 2
GA - Gabon 2
GR - Grecia 2
GY - Guiana 2
KH - Cambogia 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
MM - Myanmar 2
RS - Serbia 2
Totale 23.672
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.175
Singapore 1.148
Ashburn 1.097
San Jose 777
Hong Kong 600
Chandler 534
Woodbridge 523
Milan 471
Frankfurt am Main 458
Wilmington 380
Houston 354
Dublin 352
Fairfield 298
Toronto 297
Ho Chi Minh City 295
Jacksonville 274
New York 258
Dearborn 252
Dallas 231
Council Bluffs 218
Santa Clara 216
Los Angeles 215
Hanoi 206
Beijing 169
Seattle 143
Chicago 137
The Dalles 136
Vienna 133
Princeton 130
Cambridge 109
Nanjing 98
Rome 98
Shanghai 85
Columbus 80
Buffalo 77
Boardman 74
Lauterbourg 72
São Paulo 69
Orem 67
Hefei 64
Phoenix 63
Seoul 62
Helsinki 53
Jakarta 52
Lachine 51
Guangzhou 48
Moscow 48
Tokyo 48
Munich 46
Denver 44
London 44
Atlanta 41
Da Nang 40
Warsaw 40
Brooklyn 39
Chennai 39
Brussels 37
Lawrence 36
Montreal 35
Nanchang 33
Haiphong 31
Dong Ket 30
Ottawa 30
Johannesburg 29
Nuremberg 26
San Diego 26
Shenyang 26
Dhaka 25
Pune 25
Baghdad 24
Stockholm 23
Tianjin 23
Boston 22
Fremont 22
Istanbul 22
Altamura 21
Biên Hòa 20
Lappeenranta 20
Brasília 19
Changsha 19
Tashkent 19
Andover 18
Falls Church 18
Manchester 18
Mumbai 18
Poplar 18
Rio de Janeiro 18
Amsterdam 17
Carate Brianza 17
Jinan 17
Zhengzhou 17
Belo Horizonte 16
Norwalk 16
Quito 16
Charlotte 15
Hải Dương 15
Jiaxing 15
Lahore 15
Monza 15
Ankara 14
Totale 15.084
Salva come PNG Salva come JPEG
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 584
QT interval and dispersion in drug-free anorexia nervosa adolescents: a case control study 515
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents 511
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 486
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 480
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 462
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 458
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 457
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer’s disease 456
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 452
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 441
Anorexia nervosa in adolescent girls and celiac disease serology 422
Behavioural anomalies in neurodegenerative diseases: role of the immune response 399
The one-carbon metabolism in anorexia nervosa of the restrictive type 393
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 388
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 387
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 387
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 376
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 376
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 376
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 368
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 364
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 358
New insights into the genetic etiology of Alzheimer's disease and related dementias 351
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 345
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 342
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 340
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 340
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 335
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 332
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 331
Blood-based biomarkers of neuroinflammation in alzheimer’s disease: A central role for periphery? 328
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 319
Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation 318
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 315
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa 314
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 307
Beta-amyloid plasma levels in adolescents with anorexia nervosa of the restrictive type 298
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 297
MAPK phosphorylation in fibroblasts from Alzheimer's disease patients: ERK involvement in EAAT1 expression and modulation with disease severity 295
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 294
Anorexia nervosa of the restrictive type and celiac disease in adolescence 292
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 290
Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor 289
Modulation of mapk phosphorylation in fibroblasts from alzheimer’s patients: the erk involvment in ad severity and eaat1 expression 281
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 279
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 279
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 278
the MonzALS collaborative network 273
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 273
Erk signalling modulates app metabolism, tau phosphorylation and eaat1 processing in fibroblasts from alzheimer’s patients 272
CLEARANCE OF BETA-AMYLOID OLIGOMERS BY PERIPHERAL MONOCYTES: FURTHER OBSERVATIONS REGARDING THE MODULATORY ROLE OF DONEPEZIL 269
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 266
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 259
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 255
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 246
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 245
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review 242
Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients 241
Affective states and pathology in adolescents with borderline personality 239
Behavioural Anomalies in Neurodegenerative Diseases: Role of the Immune Response 235
Role of donepezil in influencing endogenous immune response against abeta, an ex vivo and in vitro study 228
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data 219
Plasma anti-amyloid-β autoantibodies in all Alzheimer disease types 219
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 212
Immune response against beta-amyloid is modulated by acetyl-cholinesterase inhibitors 210
Acetyl-Cholinesterase Inhibitors Modulate The Autoimmune Response Against Beta-Amyloid 208
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 207
Donepezil modulates the endogenous immune response in Alzheimer’s disease, an ex vivo and in vitro study 203
Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome 200
Further ex vivo evidence for a role of donepezil in the modulation of the immune response 190
Nilotinib or Dasatinib, but not Imatinib, might reduce Plasma Beta-Amyloid in Leukemia Patients : Implications gor Alzheimer’s Disease 188
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 186
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 184
Whole-blood global DNA methylation and phenotypic variability in ALS 183
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 176
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 152
Cardiopulmonary and skeletal muscle strategies underlying exhaustive exercise in adults with glycogen storage disease type III 138
Cerebrospinal fluid CEFA composition is enriched in saturated fatty acids and it is altered in Alzheimer's Disease 117
Dementia risk factors and biomarkers in subjective cognitive decline: real world evidence from the monza brain health service 9
Totale 24.429
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.242
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022703 0 0 0 110 71 67 55 50 48 61 85 156
2022/20231.924 192 525 218 207 131 281 36 108 129 25 44 28
2023/20241.311 62 60 71 66 161 323 233 46 59 23 18 189
2024/20253.070 171 277 212 113 238 166 207 141 304 477 263 501
2025/20268.900 1.058 474 665 850 1.123 461 1.387 372 686 833 491 500
2026/20271.656 232 435 937 52 0 0 0 0 0 0 0 0
Totale 24.429